Download full-text PDF |
Source |
---|
Rev Med Suisse
January 2025
Service de dermatologie et vénéréologie, Hôpitaux universitaires de Genève, 1211 Genève 14.
This article focuses on two key innovations in dermatology: post-exposure prophylaxis for sexually transmitted infections (STIs) and new therapeutic options for inflammatory skin diseases. New European and American guidelines for doxycycline post-exposure prophylaxis (Doxy PEP) aim to prevent STIs in men who have sex with men (MSM) and individuals on HIV pre-exposure prophylaxis (PrEP). Doxy PEP is effective against syphilis and chlamydia, but its efficacy is limited by growing gonorrhea resistance.
View Article and Find Full Text PDFBMC Infect Dis
December 2024
Santé Publique France, the National Public Health Agency, Saint-Maurice, 94415, France.
Background: The prevalence of syphilis, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG) in men who have sex with men (MSM) is very high. As these bacterial sexually transmitted infections (bSTIs) are frequently asymptomatic, they are often undiagnosed and therefore untreated. We aimed to characterize the profile of MSM who reported bSTI screening and diagnosis in the previous 12 months, and to identify the factors associated with a diagnosis of a bSTI among MSM in France.
View Article and Find Full Text PDFJ Fr Ophtalmol
October 2023
Département d'ophtalmologie, centre de référence des maladies rares, DHU Sight Restore, université Paris VI, hôpital Pitié-Salpêtrière, boulevard de l'hôpital, 75013 Paris, France.
Rev Med Interne
December 2024
Service de médecine interne, centre hospitalier d'Agen, 21, route de Villeneuve, 47923 Agen, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!